Amendment No. 1 to Warrant Agreement between The Immune Response Corporation and Spencer Trask Ventures, Inc.

Summary

This amendment updates a previous warrant agreement between The Immune Response Corporation and Spencer Trask Ventures, Inc., changing the number of units from 50 ($5,000,000) to 80 ($8,000,000). All other terms of the original agreement remain unchanged. The amendment is effective as of March 7, 2006, and is binding upon execution by both parties.

EX-10.200.1 22 a18840orexv10w200w1.htm EXHIBIT 10.200.1 exv10w200w1

Exhibit 10.200.1

AMENDMENT NO. 1 TO
WARRANT AGREEMENT

This Amendment No. 1 to Warrant Agreement (the “Amendment”) is effective as of March 7, 2006, and amends the WARRANT AGREEMENT, dated as of February 22, 2006 (the “Agreement”), by and between The Immune Response Corporation, a Delaware corporation, and Spencer Trask Ventures, Inc.

1. In the first WHEREAS clause of the Agreement, the phrase “50 units ($5,000,000)” is amended to instead read “80 units ($8,000,000).”

2. Except as expressly amended hereby, the Agreement remains unchanged and in full force and effect.

3. This Amendment may be executed in counterparts and each of such counterparts shall for all purposes be deemed to be an original, and such counterparts shall together constitute one and the same instrument.

IN WITNESS WHEREOF, the undersigned have executed, or have caused to be executed, this Amendment as of the date first written above.


	THE IMMUNE RESPONSE CORPORATION

	By:

		Name:
		Title:


Attest:


Secretary
	SPENCER TRASK VENTURES, INC.

	By:

		Name: William P. Dioguardi
		Title: President